Related Experiment Video
Updated: Mar 30, 2026
09:07
Author Spotlight: Advancing Endoscopic Ossiculoplasty – Techniques, Innovations, and Practical Guidance for Clinical Integration
Published on: January 26, 2024
3.6K
New Insights into Eosinophilic Otitis Media.
Hiromi Kanazawa1, Naohiro Yoshida2, Yukiko Iino3
1Department of Otolaryngology, Jichi Medical University Saitama Medical Center, 1-847 Amanuma, Omiya-ku, Saitama, 330-8503, Japan. hkanazawa@jichi.ac.jp.
Current Allergy and Asthma Reports
|November 8, 2015
Summary
Eosinophilic otitis media (EOM), often seen in asthma patients, involves eosinophils and IgE in middle ear fluid. A new severity score correlates with local IgE and helps manage this intractable condition.
Area of Science:
- Otolaryngology
- Allergy and Immunology
- Pulmonology
Background:
- Eosinophilic otitis media (EOM) is a severe, intractable middle ear inflammation.
- It primarily affects patients with bronchial asthma (BA).
- EOM is characterized by eosinophil-rich, IgE-laden middle ear effusions.
Purpose of the Study:
- To introduce and validate a severity score for EOM.
- To correlate this score with local immunoglobulin E (IgE) levels.
- To identify clinical risk factors associated with EOM severity.
Main Methods:
- Development and application of a novel EOM severity scoring system.
- Measurement of local IgE levels in middle ear effusion.
- Analysis of clinical data including body mass index and asthma duration.
Main Results:
- The proposed severity score demonstrated a significant correlation with local IgE levels.
- Higher scores were associated with increased inflammation and difficulty in treatment.
- Body mass index and duration of bronchial asthma were identified as risk factors.
Conclusions:
- The EOM severity score is a valuable tool for assessing disease intensity.
- Early diagnosis and appropriate management are crucial to prevent hearing loss.
- Understanding risk factors aids in proactive patient care for EOM.
Related Concept Videos
01:26Asthma-II: Pathophysiology and Classification
4.9K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.9K
01:30Asthma-IV: Diagnostic and Management
3.3K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.3K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.3K
01:20Asthma: Pathogenesis and Management
1.7K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.7K
01:14Atypical Pneumonia
38
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
38
01:29Microbiota of the Respiratory Tract
29
The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more...
29